LightDark Log in Sign up

‹ Back to screener

MAXHEALTH.NS Max Healthcare Institute Ltd.

Healthcare

Price history

1M 6M 1Y 3Y Max
2025-08-21 ₹1250.10
2026-08-21 ₹997.80
Change over window -20.18%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 70.6%
Trailing 20-day average 57.3%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 1811091 1277636 70.55%
2026-08-27 1471151 909561 61.83%
2026-08-26 1348082 695291 51.58%
2026-08-25 1889964 1018218 53.87%
2026-08-24 1997268 1181129 59.14%
2026-08-21 1237284 617361 49.90%
2026-08-20 1658842 972632 58.63%
2026-08-19 1320461 859270 65.07%
2026-08-18 2219107 1011891 45.60%
2026-08-17 2340277 1242892 53.11%
2026-08-14 4051822 2245357 55.42%
2026-08-13 2871456 1054872 36.74%
2026-08-12 2762821 1557515 56.37%
2026-08-11 2892166 1557878 53.87%
2026-08-10 2126362 1501224 70.60%
2026-08-07 1189799 729175 61.29%
2026-08-06 1728681 1173915 67.91%
2026-08-05 1171384 695011 59.33%
2026-08-04 1492388 966166 64.74%
2026-08-03 1187048 591303 49.81%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers MAXHEALTH.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
26 Aug 2022 Abhay Soi Promoters Buy Off Market 6874447 6880 23.80% XBRL
26 Aug 2022 Kayak Investments Holding Pte. Ltd. Promoters Sell Off Market 6874447 6880 0.00% XBRL
17 Aug 2022 Kayak Investments Holding Pte. Ltd. Promoters Sell Market Sale 260196762 91858199597 0.71% XBRL
06 Apr 2022 Kayak Investments Holding Pte. Ltd. Promoters Sell Market Sale 96958852 32968167984 27.54% XBRL
17 Dec 2021 Ruchi Mahajan - Sell Market Sale 17000 6799150 0.00% XBRL
17 Dec 2021 BalKishan Sharma - Sell Market Sale 13000 5265000 0.01% XBRL
15 Dec 2021 Sandeep Tanwar - Sell Market Sale 32527 12444064 0.00% XBRL
15 Dec 2021 Nidhi M Dev - Sell Market Sale 3985 1590015 0.00% XBRL
15 Dec 2021 Manish Luthra - Sell Market Sale 4000 1590000 0.00% XBRL
15 Dec 2021 BalKishan Sharma - Sell Market Sale 25749 10299600 0.01% XBRL
15 Dec 2021 Poonam Das - Pledge Pledge Creation 84722 33837967 0.01% XBRL
14 Dec 2021 Vinita Jha - Sell Market Sale 5000 1904450 0.00% XBRL
14 Dec 2021 Sandeep Budhiraja - Sell Market Sale 30000 11791300 0.02% XBRL
14 Dec 2021 Sandeep Dogra - Sell Market Sale 22262 8840352 0.00% XBRL
07 Dec 2021 Sandeep Dogra - Pledge Invoke Invocation of pledge 15685 5940090 0.01% XBRL
07 Dec 2021 Sandeep Dogra - Pledge Invoke Invocation of pledge 5432 2053300 0.01% XBRL
07 Dec 2021 Sandeep Dogra - Pledge Invoke Invocation of pledge 35143 13319197 0.00% XBRL
07 Dec 2021 Arpita Mukherjee - Sell Market Sale 5000 1885000 0.00% XBRL
06 Dec 2021 Sameer Poddar - Pledge Pledge Creation 25075 9359244 0.00% XBRL
06 Dec 2021 Sachin Malhotra - Pledge Pledge Creation 21435 8038000 0.00% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers MAXHEALTH.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹1000.00 INR (live) · fetched 2026-08-23 23:37 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
67.47
P/E = Price / EPS
Source trace
P/E = Price / (ProfitLossForPeriod / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹1,000.00 / (₹14,424,100,000 / 973,130,000 shares) = ₹1,000.00 / ₹14.82 EPS
FY2025-26 · Annual filing
ROE
13.42%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitLossForPeriod / EquityAttributableToOwnersOfParent → ₹14,424,100,000 / ₹107,466,300,000 = 13.42%
FY2025-26 · Annual filing
Debt/Equity
0.32
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹34,783,600,000 / ₹107,466,300,000 = 0.32
FY2025-26 · Annual filing
Current Ratio
0.89
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹19,447,900,000 / ₹21,869,400,000 = 0.89
FY2025-26 · Annual filing
ROCE
13.77%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹19,589,200,000 / (₹107,466,300,000 + ₹34,783,600,000) = 13.77%
FY2025-26 · Annual filing
Dividend Yield
0.15%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹1,456,200,000 / 973,130,000 shares) / ₹1,000.00 = ₹1.50 / ₹1,000.00
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 22.4%
Net Profit (3y) N/A
Revenue (5y, 3.0y actual) 22.4%
Net Profit (5y) N/A
Revenue (10y, 3.0y actual) 22.4%
Net Profit (10y) N/A

Operating Margin Trend

Eroding

FY2022-23 25.2%
FY2023-24 26.4%
FY2024-25 23.4%
FY2025-26 23.4%

ROCE Trajectory

FY2022-23 14.2%
FY2023-24 14.7%
FY2024-25 13.3%
FY2025-26 13.8%

Earnings Quality

Needs net profit and CFO for 3+ stored years; only 2 on file.

Sector-Relative Percentile (Healthcare)

ROE 43th
ROCE 33th
Debt/Equity 26th
P/E 33th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹1,422.90 Cr. ₹1,542.95 Cr. ₹1,707.46 Cr. ₹1,868.31 Cr. ₹1,909.74 Cr. ₹2,027.57 Cr. ₹2,135.47 Cr. ₹2,067.52 Cr. ₹2,142.89 Cr. ₹2,366.17 Cr. RevenueFromOperations
Net Profit ₹250.69 Cr. incl. minority ₹251.54 Cr. ₹236.27 Cr. ₹281.81 Cr. ₹238.80 Cr. ₹319.00 Cr. ₹307.97 Cr. ₹491.30 Cr. ₹300.92 Cr. ₹342.22 Cr. ₹322.96 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers MAXHEALTH.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitLossForPeriod14424100000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital973130000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets19447900000.0
CurrentLiabilities21869400000.0
EquityAttributableToOwnersOfParent107466300000.0
BorrowingsCurrent + BorrowingsNoncurrent34783600000.0

My notes